pyrans 2a-i in 82-97% yield with excellent diastereose-
lectivity (Scheme 1).13 Interestingly, the reaction is remark-
ably tolerant to a wide array of substituents. For example
aryl-, R-branched alkyl-, alkyl halide-, and alkene-containing
substituents (entries 1-5), â-keto esters (entry 6), and hy-
droxymethyl derivatives (entries 7-9) are suitable substrates.
then subjected to cross-metathesis by using the second-
generation Grubbs’ catalyst, to afford the corresponding R,â-
unsaturated ketone.17 Selective hydrogenation of the alkene
with Wilkinson’s catalyst furnished the aryl ketone 7 in 74%
yield from 6. Treatment of the δ-triethylsilyloxy aryl ketone
7 with bismuth tribromide and triethylsilane at room tem-
perature, followed by in situ removal of the tert-butyldim-
ethylsilyl group afforded (-)-centrolobine (4) in 93% yield,
with excellent diastereoselectivity. Synthetic (-)-centrolobine
(4) was identical in all respects with the reported spectral
data for the natural substance (1H/13C NMR and IR),
Scheme 2. Retrosynthetic Analysis for (-)-Centrolobine;
Potential Reductive Etherification Reactions
including optical rotation [R]22 -90.3 (c ) 0.88, CHCl3)
D
{lit.6b [R]D -92.2 (c ) 1, CHCl3)}. Overall, this total
synthesis was accomplished in 5 steps from aldehyde 5, in
53% overall yield, making it the most efficient route
developed to date.
The alternative approach to (-)-centrolobine (4) involved
the reductive coupling of a benzylic triethylsilyl ether ii
(Scheme 2; Route B). Treatment of the ketone 8, which was
prepared in 4 steps by using an analogous reaction sequence,
with bismuth tribromide and triethylsilane furnished none
of the desired product. This observation is presumably the
result of the solvolysis of the activated benzylic triethylsilyl
ether and/or alcohol formed through protodesilylation.
(-)-Centrolobine A (4) is an antibiotic that was isolated
from the heartwood of Centrolobium robustum and from the
stem of Brosimum potabile in the amazon rain forest.6
Solladie and Rychnovsky have recently completed indepen-
dent enantioselective total syntheses of this agent, and thereby
determined its absolute configuration.14 We envisioned that
the reductive etherification using bismuth tribromide and
triethylsilane would provide an expeditious route to this
agent, as outlined in Scheme 2.
Scheme 4. Attempted Reductive Etherification with the
Benzylic Triethylsilyl Ether 8
Scheme 3. Stereoselective Synthesis of (-)-Centrolobine with
an Intramolecular Reductive Etherification
In conclusion, we have demonstrated that the intramo-
lecular reductive etherification using bismuth tribromide and
triethylsilane provides a versatile route for 2,6-disubstituted
tetrahydropyrans. These studies also provide additional
support for the notion that the hydrolysis of bismuth
tribromide leads to the generation of hydrogen bromide,
which functions as a Brønsted acid catalyst. Finally, this
methodology was highlighted in an expeditious total syn-
thesis of the antibiotic, (-)-centrolobine.
Acknowledgment. We sincerely thank the National
Institutes of Health (GM58877) for generous financial
support. We also thank Johnson and Johnson for a Focused
GiVing Award, and Pfizer Pharmaceuticals for the CreatiVity
in Organic Chemistry Award. The Camille and Henry
Dreyfus Foundation is thanked for a Camille Dreyfus
Teacher-Scholar Award (P.A.E.).
The initial approach to (-)-centrolobine (4) involved the
examination of the reductive etherification of an aryl ketone
i (Scheme 2; Route A). Enantioselective allylation of
aldehyde 5,15 and protection of the resulting secondary
alcohol (95% ee), furnished the triethysilyl ether 6 in 77%
overall yield, as detailed in Scheme 3.16 The alkene 6 was
(12) For an example of protodesilylation of alkyl triorganosilyl ethers
with bismuth bromide, see: Bajwa, J. S.; Vivelo, J.; Slade, J.; Repic, O.;
Blacklock, T. Tetrahedron Lett. 2000, 41, 6021.
(13) For a discussion of substituent effects on the stereochemical outcome
of additions to tetrahydropyran-derived oxocarbenium ions, see: Romero,
J. A. C.; Tabacco, S. A.; Woerpel, K. A. J. Am. Chem. Soc. 2000, 122, 168.
(14) (a) Colobert, F.; Des Mazery, R.; Solladie, G.; Carreno, M. C. Org.
Lett. 2000, 4, 1723. (b) Marumoto, S.; Jaber, J. J.; Vitale, J. P.; Rychnovsky,
S. D. Org. Lett. 2002, 4, 3919.
Supporting Information Available: Experimental pro-
cedures and spectroscopic data for all new compounds. This
material is available free of charge via the Internet at
OL035438T
(15) Jones, G. B.; Heaton, S. B. Tetrahedron: Asymmetry 1993, 4, 261.
(16) Keck, G. E.; Tarbet, K. H.; Geraci, L. S. J. Am. Chem. Soc. 1993,
115, 8467.
(17) Chatterjee, A. K.; Morgan, J. P.; Scholl, M.; Grubbs, R. H. J. Am.
Chem. Soc. 2000, 122, 3783. For a recent review on olefin cross-metathesis,
see: Connon, S. J.; Blechert, S. Angew. Chem. Int. Ed. 2003, 42, 1900.
Org. Lett., Vol. 5, No. 21, 2003
3885